Aztreonam Injection

POLYREST Injection contains Polymyxin B, a potent polypeptide antibiotic used in the treatment of severe Gram-negative bacterial infections. It works by binding to the bacterial cell membrane, altering its permeability, and leading to cell death. It is particularly effective against multidrug-resistant pathogens, including Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae, making it a valuable choice in critical and hospital-acquired infections. Uses / Indications: Severe Gram-negative bacterial infections Bloodstream infections (septicemia) Urinary tract infections (complicated UTIs) Meningitis caused by susceptible bacteria Hospital-acquired and ventilator-associated pneumonia Infections caused by multidrug-resistant Gram-negative organisms Key Benefits: ✅ Effective against multidrug-resistant Gram-negative bacteria ✅ Essential therapy in ICU and critical infections ✅ Restores antibiotic effectiveness when other therapies fail ✅ Reliable for life-threatening hospital-acquired infections

MAGFER FC Injection is an intravenous iron preparation containing Ferric Carboxymaltose. It is specially designed for the treatment of iron deficiency anemia (IDA) in patients who cannot tolerate or do not respond adequately to oral iron therapy. It provides a stable iron complex that ensures controlled and targeted delivery of iron to the body, restoring iron stores effectively and safely. Uses / Indications: Treatment of iron deficiency anemia (IDA) Iron deficiency in chronic kidney disease (CKD) patients Post-partum anemia in women Patients intolerant or unresponsive to oral iron therapy Rapid correction of iron levels in hospitalized patients Key Benefits: ✅ Rapid replenishment of iron stores ✅ Fewer doses required compared to oral iron or other IV preparations ✅ Well tolerated with low risk of adverse effects ✅ Improves hemoglobin levels effectively

MYDIME-AV Injection is a combination of Ceftazidime, a third-generation cephalosporin antibiotic, and Avibactam, a novel non–β-lactam β-lactamase inhibitor. Ceftazidime kills bacteria by inhibiting bacterial cell wall synthesis. Avibactam prevents the degradation of ceftazidime by β-lactamase enzymes, thereby enhancing its effectiveness against resistant bacteria. This powerful combination is used for the treatment of complicated infections caused by multidrug-resistant Gram-negative bacteria, including Pseudomonas aeruginosa and Enterobacteriaceae. Uses / Indications: Complicated urinary tract infections (cUTI) Complicated intra-abdominal infections (cIAI) Hospital-acquired pneumonia (HAP), including ventilator-associated pneumonia (VAP) Infections caused by multidrug-resistant Gram-negative bacteria Key Benefits: ✅ Effective against resistant Gram-negative bacteria ✅ Broad-spectrum action with enhanced β-lactamase inhibition ✅ Strong clinical efficacy in life-threatening infections ✅ Trusted in ICU and hospital-acquired infections